Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.83 USD
+0.02 (2.16%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $0.82 -0.01 (-1.49%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 31.03% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.93 |
Next Year | -0.66 |
EPS (TTM) | -1.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 38.15M | 38.81M | 152.90M | 182.87M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 40.58M | 41.05M | 156.29M | 209.72M |
Low Estimate | 34.20M | 36.54M | 147.60M | 155.00M |
Year ago Sales | 36.01M | 33.75M | 146.03M | 152.90M |
Year over Year Growth Est. | 5.95% | 14.98% | 4.70% | 19.60% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.25 | -0.93 | -0.66 |
# of Estimates | 4 | 4 | 2 | 4 |
Most Recent Consensus | -0.28 | -0.30 | -1.08 | -0.96 |
High Estimate | -0.15 | -0.14 | -0.78 | -0.34 |
Low Estimate | -0.34 | -0.31 | -1.08 | -0.96 |
Year ago EPS | -0.30 | -0.36 | -1.25 | -0.93 |
Year over Year Growth Est. | 13.33% | 30.56% | 25.60% | 29.03% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 3 | 2 | 4 |
Up Last 30 Days | 3 | 3 | 2 | 4 |
Up Last 60 Days | 3 | 3 | 2 | 4 |
Down Last 7 Days | 1 | 1 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.25 | -0.93 | -0.66 |
7 Days Ago | -0.27 | -0.28 | -1.08 | -0.80 |
30 Days Ago | -0.30 | -0.31 | -1.25 | -0.89 |
60 Days Ago | -0.30 | -0.31 | -1.26 | -0.90 |
90 Days Ago | -0.30 | -0.31 | -1.26 | -0.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.26 | -0.25 | -0.93 | -0.66 |
Zacks Consensus Estimate | -0.26 | -0.25 | -0.93 | -0.66 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.32 | -0.36 | -0.30 | NA |
Estimate | -0.29 | -0.33 | -0.29 | -0.28 | NA |
Difference | 0.09 | 0.01 | -0.07 | -0.02 | 0.00 |
Surprise | 31.03% | 3.03% | -24.14% | -7.14% | 0.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more